1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25 | On 09/19/2024, Licensing Program Analyst (LPA) Arielle Pascua arrived unannounced to this facility to conduct a case management visit. LPA was met with Facility Designated Administrator (FDA), Alfredo Cruz and explained the purpose of the visit.
Current Census was 85. A tour of the facility was conducted and a brief interview with FDA Cruz was conducted.
The purpose of this visit was to follow up on an incident report that was received by the department on 09/17/2024. The incident report states that on 09/14/2024, R1 reported that they had a severe headache and requested for their prescribed medication of Oxytocin, however staff advised that this resident was out of this PRN medication. Subsequently, R1 requested to be sent out via Emergency Services for further evaluation.
During the course of this visit, LPA obtained R1's medication administration record, physicians orders, and narcotic log.
Due to insufficient time to review documentation, the department will follow up at a later time to complete this case management visit.
No deficiencies during the course of this visit.
An exit interview was conducted, and a copy of the report was given end the of this visit.
|